Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Has results × Milk × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 631 Bevacizumab 550 Paclitaxel 531 Carboplatin 525 Cisplatin 474 pembrolizumab 434 Gemcitabine 418 Docetaxel 411 Rituximab 383 Radiotherapy 364 Dexamethasone 345 Doxorubicin 320 Nivolumab 302 Fluorouracil 283 Capecitabine 261 Prednisone 242 Oxaliplatin 241 Erlotinib Hydrochloride 241 Etoposide 238 Lenalidomide 230 Cytarabine 228 Trastuzumab 226 Pemetrexed 218 fludarabine phosphate 207 Cetuximab 204 Leucovorin 203 Vincristine 202 Filgrastim 202 Bortezomib 191 Methotrexate 179

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00204477 2024-01-23

Soy Protein and Breast Cancer Risk Reduction

The University of Texas Medical Branch, Galveston

Phase 2 Completed

321 enrolled 14 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡